Tech Mahindra and NVIDIA unveil an AI-powered pharmacovigilance solution to enhance drug safety, reducing delays, improving ...

Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across ...

The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven advancements. Despite high costs, growing R&D and patient safety efforts drive ...

The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics ...

Together, we are revolutionizing drug safety management ... pharmacovigilance. The pharmacovigilance industry manages over 1,000 daily cases of adverse drug reaction (ADR) for major drugs.

(MENAFN- GlobeNewsWire - Nasdaq) The US pharmacovigilance market ... a rising incidence of adverse drug reactions (ADRs), and advancements in drug safety monitoring technologies.

Regulatory Shifts and Data-Sharing Advancements Fuel Global Pharmacovigilance Growth, Opening Doors for Seamless Compliance ...